(3R,4S)-tert-Butyl 3-Amino-4-methoxypyrrolidine-1-carboxylate - CAS 121242-20-4
Catalog: |
BB062167 |
Product Name: |
(3R,4S)-tert-Butyl 3-Amino-4-methoxypyrrolidine-1-carboxylate |
CAS: |
121242-20-4 |
Synonyms: |
(3R,4S)-rel-3-Amino-4-methoxy-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester; cis-3-Amino-4-methoxy-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester |
IUPAC Name: | tert-butyl (3S,4R)-3-amino-4-methoxypyrrolidine-1-carboxylate |
Description: | (3R,4S)-tert-Butyl 3-Amino-4-methoxypyrrolidine-1-carboxylate, can be used in the synthesis of various pharmaceutical and biologically active compounds. It can be used in the preparation of new series of quinolone derivatives. |
Molecular Weight: | 216.28 |
Molecular Formula: | C10H20N2O3 |
Canonical SMILES: | CC(C)(C)OC(=O)N1CC(C(C1)OC)N |
InChI: | InChI=1S/C10H20N2O3/c1-10(2,3)15-9(13)12-5-7(11)8(6-12)14-4/h7-8H,5-6,11H2,1-4H3/t7-,8+/m0/s1 |
InChI Key: | STYSIWNZDIJKGC-JGVFFNPUSA-N |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021242923-A1 | Tlr2 modulator compounds, pharmaceutical compositions and uses thereof | 20200527 |
WO-2021215545-A1 | Anticancer combination therapy with n-(1-acryloyl-azetidin-3-yl)-2-((1h-indazol-3-yl)amino)methyl)-1h-imidazole-5-carboxamide inhibitor of kras-g12c | 20200424 |
WO-2021081207-A1 | Glp-1r modulating compounds | 20191025 |
US-2021171499-A1 | Glp-1r modulating compounds | 20191025 |
TW-202130630-A | Glp-1r modulating compounds | 20191025 |
TW-202029960-A | Novel indazole compound or its salt | 20181026 |
EP-3871673-A1 | Novel indazole compound or salt thereof | 20181026 |
US-2021395234-A1 | Novel indazole compound or salt thereof | 20181026 |
CA-3098291-A1 | Tetrahydro-1 h-pyrazino[2,1 -ajisoindolylquinoline compounds for the treatment of autoimmune disease | 20180605 |
BR-112020024782-A2 | tetrahydro-1h-pyrazine [2,1-a] isoindolylquinoline compounds for the treatment of autoimmune disease | 20180605 |
Complexity: | 237 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 2 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 216.1473925 |
Formal Charge: | 0 |
Heavy Atom Count: | 15 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 216.1473925 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 64.8Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS